Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety 2018
Partner Content Partner Content Introducing SMi’s 5th conference on Drug Safety 2018 this Ju... Drug Safety London 2018
Events Partner Content World Drug Safety Congress Returns to Philadelphia April 10-... Proactive Safety, Minimizing Risk.
Views & Analysis Pharmacovigilance as a business enabler Industry may be limiting its options if safety takes a back seat to efficacy in trial design and product development.
Views & Analysis Meeting pharmacovigilance standards in the US and Europe Examining statistics on recent inspections gives insight into the issues commonly faced.
Views & Analysis Pharmacovigilance checklist: resolving common problems Though pharmacovigilance has improved in recent years, there's still much room for improvement, says Steve Jolley.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
